Radiotherapy + Systemic Therapy as Conversion Therapy for pMMR/MSS T4M0 Colon Cancer（Neo-Color）

NCT06949111 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

128

Enrollment

OTHER

Sponsor class

Conditions

Colon Cancer

Interventions

RADIATION: radiotherapy
DRUG: CAPOX
DRUG: Capecitabine
DRUG: Iparomlimab and Tuvonralimab Injection

Sponsor

Hebei Medical University Fourth Hospital